Genentech Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer
SOUTH SAN FRANCISCO, Calif.—-Genentech, Inc., a wholly owned member of the Roche Group , announced today the topline results of a Phase III trial led by the U.S. Cancer and Leukemia Group B and sponsored by the National Cancer Institute [...]
Posts under ‘Chemotherapy – Latest Cancer News’
Nuggets’ Karl to miss 3 more games for cancer therapy
Football, TV star Merlin Olsen dead
Exploiting the architecture of cancers may lead to their destruction
After making a diagnosis of cancer, clinicians have a number of treatment options. Most of these involve coordinating multiple attacks on the tumor using an arsenal of cancer-killing therapies. Chemotherapy, where toxic drugs are used to specifically kill cancer cells, is a very powerful weapon in [...]
Health Alert: Local Colon Cancer Patient
Transgene Sells Option on Cancer Vaccine to Novartis (Update2)
March 10 (Bloomberg) — Transgene SA , the French biotechnology company backed by the billionaire Merieux family, sold Novartis AG an option on rights to the experimental TG4010 cancer vaccine in a deal that may fetch as much as $960 million.
Read more on Bloomberg
Health Alert: Local Colon [...]
OSI Bid Likely to Rise as Hungry Astellas Covets Cancer Revenue
OSI Bid Likely to Rise as Astellas Seeks Cancer Sales (Update1)
March 9 (Bloomberg) — OSI Pharmaceuticals Inc .’s status as one of the few U.S. biotechnology companies with income from an approved cancer drug likely will drive up the price Tokyo-based Astellas Pharma Inc.
Read more on Bloomberg
OSI Bid Likely to Rise as Hungry Astellas Covets [...]
Koenigsfeld: Quality of life as important as the quantity
Plenty of opportunity to serve in Utah
Here are some ways to share your time and talents with others provided by 2-1-1 Information and Referral,
Read more on Deseret News
Koenigsfeld: Quality of life as important as the quantity
ROCKFORD — Dian Koenigsfeld chose not to take chemotherapy treatments for an aggressive brain cancer, “because I want to live [...]
Loyola Study Finds The Hormone Estrogen Inhibits A Protein That Causes Normal Cell Death In Breast Tumors
Researchers discover key reason why form of leukemia progresses from chronic phase to blast crisis
Researchers have discovered a key reason why a form of leukemia progresses from its more-treatable chronic phase to a life-threatening phase called blast crisis.
Read more on News-Medical-Net
Loyola Study Finds The Hormone Estrogen Inhibits A Protein That Causes Normal Cell Death In [...]
ON TOWARD THE NEXT CHALLENGE
Cleveland HeartLab Raises $3 Million, Announces Leadership Team and Advisors
CLEVELAND—-Cleveland HeartLab LLC today announced that it has completed a $3.0-million fundraising round. The company’s new shareholders include local business leaders, and Glengary LLC, Second Generation Ltd. and Zapis Capital Group LLC.
Read more on Business Wire via Yahoo! Finance
ON TOWARD THE NEXT CHALLENGE
L’Observateur RESERVE — When [...]
The Good Fight: Greg Holmes
Volunteers give cancer patients rides to treatment
Published: Monday, March 1, 2010 at 8:00 a.m. Last Modified: Friday, February 26, 2010 at 10:24 a.m. SHREVEPORT — Stanley Davis wondered how he was going to get to the doctor when he was diagnosed with colon and prostate cancer in October.
Read more on The Daily Comet
The Good Fight: [...]
Novelos Therapeutics Pivotal Phase 3 Lung Cancer Trial Does Not Meet The Primary Survival Endpoint
Kinex Pharmaceuticals Initiates A Phase 2 Clinical Trial Of KX2-391 In Patients With Prostate Cancer
Kinex Pharmaceuticals opened a Phase 2 clinical trial to evaluate the safety and efficacy of KX2-391 in patients with bone-metastatic, castrate-resistant prostate cancer (CRPC) who have not had prior chemotherapy. The study will take place at the University of Chicago, the [...]
Rodney Alcala’s Final Revenge
Light Sciences Oncology Meets A Major Milestone In Aptocine Development With Target Enrollment In Phase 3 MCRC Trial
Light Sciences Oncology, Inc. (LSO) announced the achievement of a major milestone in its late-stage clinical development of Aptocine™ (talaporfin sodium) for treatment of solid tumors. LSO’s global Phase 3 trial of Aptocine in metastatic colorectal cancer (MCRC) [...]